Alzheimer’s Association Corner
Formed in 1980, the Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. The Alzheimer’s Association® is committed to accelerating the global effort to eliminate Alzheimer’s disease. One of the Association’s most significant responsibilities is to continue its leadership as a catalyst and convener, bringing researchers together to accelerate the pace of discovery toward methods of treatment, prevention and, ultimately, a cure. As a global leader in Alzheimer's research, the Alzheimer's Association® operates in a spirit of inclusiveness, seeking partnerships throughout the scientific community to propel the field of Alzheimer's research forward. We lead through innovation, bringing together government, industry and academia to increase funding and accelerate discovery.
Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART).
ISTAART convenes the global Alzheimer's and dementia science community. Members share knowledge, fuel collaboration and advance research to find more effective ways to detect, treat and prevent Alzheimer's and other dementias.
Experiencing less frequent bowel movements is associated with cognitive decline, according to new research reported today at the AAIC
Research reported at AAIC shows a simple, finger prick blood test shows promise in the ability to detect Alzheimer’s disease.
New Research from AAIC reports on the largest clinical trial to investigate whether a hearing loss treatment intervention can reduce risk of cognitive decline.
New Research presented at the AAIC shows new opioid use in older adults with dementia is associated with a significantly increased risk of death.
New data reported by Eli Lilly from the TRAILBLAZER-ALZ 2 trial of donanemab at the AAIC, shows that the drug is effective in delaying Alzheimer’s progression.
The first-ever county-level estimates of the prevalence of people with Alzheimer’s dementia, in all 3,142 United States counties. Released at AAIC
New Research presented at the AAIC shows provide details on two new CRISPR-based strategies which offer hope for next-generation Alzheimer’s treatments.
The Dementia Researcher / ISTAART Relay Podcast with Dr David Cash interviewing Dr Shana D Stites representing the Diversity & Disparities PIA.
The Dementia Researcher / ISTAART Relay Podcast with Dr Maura Malpetti interviewing Beth Eyre, representing the Vascular Cognitive Disorders PIA
The Dementia Researcher / ISTAART Relay Podcast is back. In this show Dr Imre Lengyel interviews Dr Maura Malpetti, representing the Frontotemporal Dementia PIA
Dementia Researcher secures £1.1 million of funding from charity partners and the NIHR to enable a further 5 years of ECR support.
ISTAART Partnering with Research Participants PIA Blog. Dr Diana Karamacoska shares tips on making research accessible, inclusive & equitable (also in Spanish)
Beth Eyre talks about her experiences as an ISTAART Ambassador and the brilliant benefits the programme could bring for you.
Dr Claire McEvoy & Daniel Gibbs provide a researcher and participant perspective on diet and cognition in this ISTAART Perspectives Podcast
If you’re based in a Low- and Middle-income Country, the ISTAART Diversity and Disparities Professional Interest Area (PIA) needs your help.
Experiences of racism are associated with lower memory scores & worse cognition in midlife, in old age, and especially among Black people
Persistent loss of smell may be a better predictor of long-term cognitive and functional impairment than severity of the initial COVID-19 infection
ALZ-NET — a new platform that will collect long-term clinical and safety data from patients treated with Alzheimer’s disease therapies
Are we ready for blood based biomarkers? New publication shared at the AAIC explores the benefits and risks of their use in clinical practice and research
In the last show of this season Erica Dove interviews Professor Charlotte Teunissen from UMB Amsterdam discussing her work and the Biofluid Based Biomarkers PIA
The ISTAART Relay Podcast is back for Day 4, today Dr Louise Ince interviews Erica Dove discussing Technology and Dementia and their PIA
Day Three of the ISTAART Relay show and today it is all about Dr Louise Ince from University of Texas at Austin and the Immunity and Neurodegeneration PIA.
Day Two of the ISTAART PIA Podcast and today Dr Rik Ossenkoppele interviews Dr Hamid Sohrabi from Murdoch University, Australia
The ISTAART Relay Podcast is back, in the 1st show we hear from Dr Rik Ossenkoppele, discussing the Atypical Alzheimer’s Disease PIA
Fernando & Clara talk to Dr Yue Leng & Helen Rochford-Brennan to get a researcher & lived experience perspective on Sleep, Research and Dementia.
Adam Smith hosts a discussion with his ISTAART colleagues Dr Beth Shaaban, Dr Lindsay Welikovitch & Wagner Brum to discuss the findings of their ISTAART / UCL ECR Survey
Global survey of early career researchers reveals their feelings on a wide range of topics including job satisfaction, workplace, discrimination + more
STAART PIA to Elevate Early Career Researchers Blog, Dr James Quinn reflects on his move from the UK to the USA and his time as a postdoc.
Fernando Peres & Dr Clara Domínguez Vivero talk with a CST expert and an Alzheimer’s Association Volunteer – exploring user and researcher perspectives
Dr Claire Sexton talks with Cindy Miller & Professor Bruce Miller about their new book, which brings together Neuroscience and a story family and dementia
Dr Anna Volkmer talks with colleagues from the ISTAART PIA to Elevate Early Career Researchers, as they launch their Worldwide Dementia ECR Survey.
A hurdle in developing Alzheimer’s theraputics that work for people of all ethnicities is recruitment & retention of underrepresented groups in clinical trials
New research reports associations between COVID-19, and persistent cognitive deficits, including the acceleration of Alzheimer’s disease pathology and symptoms.
Transgender adults in the U.S. are more likely to report worsening memory & depression compared to cisgender adults. According to 2 studies reported at the AAIC
Positive trends in global education will decrease dementia prevalence but trends in smoking, BMI & high blood sugar counteract the decrease.
Dr Claudio Babiloni (Electrophysiology) is back to interview Dr Joe Kane (Lewy body Dementia) discussing their work, ISTAART and hot topics
Dr Betty Tijms (Neuroimaging) interviews Dr Claudio Babiloni (Electrophysiology) discussing their work, ISTAART and hot topics in the field.
In the third show Professor Jennifer Whitwell (Atypical AD PIA) interviews Dr Betty Tijms (Neuroimaging PIA) discussing their work, and hot topics in the field.
Professor Zahinoor Ismail (Neuropsychiatric Syndromes) talks to Professor Jennifer Whitwell (Atypical AD) discussing their work & hot topics
The Relay Podcast is back for a second season – Dr Joe Kane (Lewy body dementia) talks with Professor Zahinoor Ismail (Neuropsychiatric Syndromes)
Senior Director, Scientific Programs and Outreach leading work on ISTAART, Alzheimer’s Association International Conference (AAIC).
Dr Anna Volmer talks with Adam Smith, James Quinn, Beth Shaaban and Naiara Demnitz, sharing news of their new ISTAART PIA to Elevate Early Career Researchers
Associate Director of Science Engagement and Outreach at the Alzheimer’s Association, working to support ISTAART, Conference delivery and much more.
In this last of this series of the ISTAART PIA Relay Podcast Dr Sietske Sikkes interviews Professor David Scott from the Perioperative Cognition & Delirium PIA
Part Four of the ISTAART PIA Relay Podcast. Today Dr Cécilia Samieri interviews Dr Sietske Sikkes representing the Subjective Cognitive Decline PIA.
A five-part special relay podcast series,. Today Dr Prashanthi Vemuri interviews Dr Cécilia Samieri talking Nutrition and Metabolic Disorders in Dementia
Professor Henrik Zetterberg interviews Dr Prashanthi Vemuri discussing hot topics in research the ISTAART Reserve, Resilience, and Protective Factors PIA
In this 1st of our new ISTAART Relay Podcasts Professor David Scott interviews Professor Henrik Zetterberg discussing blood-based biomarks and ISTAART
The Alzheimer’s Association is pausing the International Research Grant Program (IRGP) letter of intent submission process – New deadlines for the applications submission process for the IRGP will be confirmed soon.
This month we will be in Los Angeles recording a podcast each day from the Alzheimer’s Association International Conference (14th to 18th), and releasing them the very next day, so those who can’t attend don’t miss out. If you are there, why not join us on a panel?
In today’s JAMA Neurology, researchers led by Oskar Hansson, Lund University, Sweden, report how a fully automated immunoassay for plasma Aβ performed when they put it through its paces.
Subscribe now, and don’t miss our daily podcast from the AAIC the world largest dementia conference
Experience year-round engagement with the Alz and dementia community and help stimulate scientific discussion in the field.